Superior vena cava syndrome due to metastasis from urothelial cancer: A case report and literature review

Superior vena cava (SVC) syndrome is caused by compression or obstruction of the SVC. We report here in a case of SVC syndrome due to lymph node metastasis from urothelial cancer to the mediastinum and lung. The origin of metastasis was determined by computed tomography (CT)-guided biopsy of metastases. After radiotherapy to the mediastinum with glucocorticoid failed, anticancer pharmacotherapy including paclitaxel, gemicitabine, and cisplatin proved effective and SVC syndrome resolved. But patient died from cerebral bleeding from newer brain metastases 10 months later.

• Publication year

  2013

• Venue

  Urology Annals

• Publication date

  2013-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4103/0974-7796.120313PMID 24311914PMCID 3835992
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endovascular stenting to treat obstruction of the superior vena cava

  2008cited by this paper
• Superior vena cava syndrome caused by an intravascular thrombosis due to underlying prostate carcinoma.

  2008cited by this paper
• Superior vena cava syndrome.

  2007cited by this paper
• Clinical practice. Superior vena cava syndrome with malignant causes.

  2007influential reference
• Superior vena cava syndrome caused by supraclavicular lymph node metastasis of renal cell carcinoma

  2007cited by this paper
• Superior Vena Cava Syndrome with Malignant Causes

  2007cited by this paper
• Chemotherapy with gemcitabine, paclitaxel, and cisplatin in the treatment of patients with advanced transitional cell carcinoma of the urothelium.

  2006cited by this paper
• Descending Tumor Thrombus from Renal Cell Carcinoma Metastases with SVC Syndrome

  2006cited by this paper
• Case report. Renal cell carcinoma vertebral body metastasis extending into the azygos venous system causing superior vena cava obstruction.

  2005cited by this paper
• Wilms tumor presenting as superior vena cava syndrome.

  2002cited by this paper
• Superior vena cava obstruction due to prostate carcinoma.

  2000cited by this paper
• Testicular carcinoma with superior vena cava obstruction and atrial extension.

  1999cited by this paper
• Superior vena cava obstruction in prostate cancer.

  1999cited by this paper
• Clinical Outcome of Stenting in Superior Vena Cava Syndrome Associated with Malignant Tumors

  1998cited by this paper
• Metastatic carcinoma of the prostate presenting as a superior vena cava syndrome.

  1993cited by this paper
• Superior Vena Caval Obstruction due to Atrial Metastasis

  1989cited by this paper
• Superior vena cava syndrome in a 56-year-old man.

  1981cited by this paper
• The superior vena cava syndrome.

  1961cited by this paper

• Central nervous system metastasis in urothelial carcinoma: institutional experience and a comprehensive review of the literature

  2020cites this paper
• Central Nervous System Metastasis in Patients With Urothelial Carcinoma: Institutional Experience and a Comprehensive Review of the Literature.

  2019cites this paper
• Urothelial Superior Vena Cava Syndrome with Limited Response to Radiation Therapy

  2015cites this paper